Clinical Trial Update: A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 frontline therapy trial in advanced classical Hodgkin lymphoma has completed. Results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Takeda | Conditions: Hodgkin Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2018-11-27